Abstract
Post utero, persistence of the patent foramen ovale (PFO) carries mischievous potential, as it appears to have no physiologic or survival benefit for normal individuals. In states of abnormal right-sided cardiac capacitance, PFO has been implicated in worsening hypoxemia resulting from right to left intracardiac passage of deoxygenated blood. Association and causative roles of PFO in much more commonly occurring syndromes, including cerebral and cutaneous decompression disease, migraine with aura, and embolic ischemic stroke, have been suggested.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bridges ND, Hellendbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902–1908.
Ruiz LE, Alboliras ET, Pophal SG. The puncture technique: a new method for transcatheter closure of patent foramen ovale. Cathet Cardiovasc Intervent 2001;53:369–372.
Herrmann HC, Silvestry FE, Glaser R, et al. Percutaneous PFO and ASD closure in adults: results and device comparison in 100 consecutive implants at a single center. Cathet Cardiovasc Intervent 2004, in press.
Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical enmbolism: long-term risk of recurrent thromboembolic events. Circulation 2000:101:892–898.
Hung J, Landzberg MJ, Jenkins JK, et al. Closure of patent foramen ovale for paradoxical emboli: intermediate-term risk of recurrent neurological events following tanscatheter device placement. J Am Coll Cardiol 2000;35:131.
Butera G, Bini MR, Chessa M, et al. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Ital Heart J 2001;2:115–118.
Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121–1126.
Khairy P, O’Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboembolism: a systematic review. Ann Intern Med 2003;139:753–760.
Braun MU, Fassbender D, Schoen S, et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019–2025.
La Rosee K, Krause D, Becker M, et al. Transcatheter closure of atrial septal defects in adults: practicality and safety of four different closure devices used in 102 patients. Dtsch Med Wochenschr 2001; 126: 1030–1036.
Sievert H, Horvath K, Zadan E, et al. Patent foramen ovale closure in patients with transient ischemic attack/stroke. J Intervent Cardiol 2001;14:261–266.
Stauffier JC, Serra M, Juillard JM, et al. Percutaneous closure of patent foramen ovale: preliminary experience with PFO-Star. Arch Mal Coeur Vaiss 2004;97:37–41.
Schwerzmann M, Windecker S, Wahl A, et al. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 2004;90:186–190.
Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in one thousand consecutive patients. J Am Coll Cardiol 2004;43:302–309.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Landzberg, M.J. (2005). CardioSEAL®, CardioSEAL-STARFlex®, and PFO-Star® Closure of PFO. In: Herrmann, H.C. (eds) Interventional Cardiology. Contemporary Cardiology. Humana Press. https://doi.org/10.1385/1-59259-898-6:131
Download citation
DOI: https://doi.org/10.1385/1-59259-898-6:131
Publisher Name: Humana Press
Print ISBN: 978-1-58829-367-1
Online ISBN: 978-1-59259-898-4
eBook Packages: MedicineMedicine (R0)